Lol, well. Seems like there is no need to panic just yet—the defense tech money tap is still on in full force.
Yesterday, defense tech giant Shield AI announced that it has entered into a definitive agreement—pending regulatory approval—to acquire radar hotshot Echodyne in a deal valued at a whopping $5.3B.
- Shield has raised a whole gosh-darn $2.5B to fund the transaction, including $1B in Series H funding at a $28.8B post-money valuation, plus a $1B structured equity investment from Blackstone and $500M in debt financing from J.P. Morgan.
- $4.8B will be paid to Echodyne when the deal closes, and $500M is “contingent on Echodyne meeting agreed performance targets.”
“[Echodyne’s] got an amazing team, amazing product line, strong culture fit, and a strong mission fit,” Shield Co-Founder and President Brandon Tseng told Tectonic. “As Shield thinks about the future of defense, we think companies need to be able to have products that sense, think, and act around the world—that’s what autonomous systems do at the end of the day.”
Speedrunning: In case you haven’t been paying attention, Shield has been on a hell of a run lately.
- This is, in fact, the company’s second mega-raise of the year. Back in March, the company raked in $2B in financing, including a $1.5B Series G led by Advent International and JPMorganChase’s Strategic Investment Group plus $500M in Blackstone preferred equity. The deal valued Shield AI at $12.7B, up from $5.3B in 2025.
- That raise helped fund the acquisition of Aechelon Technology, which develops high-fidelity simulation, sensor modeling, and synthetic environments, back in June.
- They also unveiled X-Bat—their XL VTOL drone fighter—in October 2025, and the Navy committed $50M to the program in August 2026. Then the service committed another $150M last month. (Both investments were matched by Shield, bringing total investment to $400M.)
- Plus, the company was awarded a production contract for its flagship Hivemind autonomy software for the Collaborative Combat Aircraft (CCA) program back in June.
- Then, there are all the partnerships—Shield has teamed up with Honeywell, Leonardo, and L3Harris to make their more legacy-y platforms autonomous with Hivemind.
Meanwhile, work has ticked along on V-Bat, the company’s flagship VTOL ISR drone—Shield has inked contracts with India, Taiwan, Poland, and the US Navy for the platform in just the past year.
- Worth noting—the drone hasn’t had the easiest couple of months. Back in June, Reuters reported that about 50 of the company’s 200 upgraded drones in its internal fleet had crashed in about 18 months. Shield has denied any wrongdoing.
Sixth sense: Now Echodyne, while maybe a lil’ less flashy, ain’t doin’ too shabby itself.
The company was founded back in 2014 and builds compact, high-performance radars that can detect and track drones, aircraft, vehicles, and people. All the important stuff.
- Its secret sauce is a patented technology called “metamaterials electronically scanned array,” or MESA, which allows it to deliver the capability of a much larger, more expensive military radar in a smaller, cheaper package.
- And Echodyne has carved out quite the sweet little niche for itself in the counter-drone market—it’s got hundreds of customers across more than 40 countries and integrations into systems built by a bunch of companies you have definitely heard of (including Anduril, Northrop Grumman, and Kongsberg).
- It’s also got a bunch of contracts with the US government, including a mega $250M ceiling agreement with JIATF-401—signed in September—to supply cUAS radar to the US and other allied forces.
All in the family: This deal brings all that sensing goodness—and, importantly, all those customers and contracts and revenue—in-house at Shield.
- Per Tseng, Echodyne’s sensing capabilities complete Shield’s capability trifecta—autonomy (Hivemind), simulation capabilities (Aechelon’s stuff), and now sensing. “If you have those three things, you’re going to be the company that’s making a big impact for the warfighter on the battlefield in the future.”
- He said that Shield will maintain all of Echodyne’s customers and contracts (specifically, he said that “for a customer, there should be really no change of service whatsoever”), and that for the first year the company will operate pretty independently with “light touch integrations” with Shield.
- After that, they’ll start a “deeper level of team integrations…getting them more involved on the Shield side than they have been in the past.” That means more and more counter-drone (and other threat) sensing solutions, all under the big ol’ $28B umbrella.
“What makes the hair stand up on my arms to this day is when our products have mission impact for the customer,” Tseng said. “EchoDyne [is] delivering mission impact at scale to customers every single day… counter-drone is one of the hardest problems out there on the market [and] on the battlefield.”
Open up: We asked Tseng if this was a move towards an IPO—or at least a step towards the path leading to an IPO.
He wouldn’t comment on timing, but said that the company always has an eye towards the public markets (and the scrutiny they bring) as they build.
“At the end of the day, Shield is working to build a fantastic business and one that accomplishes our mission of protecting service members and civilians at scale,” he said. “When I think about, like, great businesses…[they] are predictable. The public markets hold them to very high standards, and we are certainly cognizant of that.”
“We think about first and foremost building that great predictable business, but then also about having the option to go public should we choose to,” he added.
Cash cow: And it doesn’t sound like this is the end of their funding push—not by a long shot. Tseng said that all of this new cash money is going towards the acquisition of Echodyne—they’ll have to raise more to get X-Bat into production (among other things).
- Worth noting the company officially unveiled a prototype of the drone-fighter this week.
“We’ve got some major projects, major products on the horizon…we will have to go and raise money for X-Bat production,” he said. “We will raise additional capital in the future. As I’ve told folks, I’ve raised money every single year like clockwork.”
“As investors have gotten to know the Shield story and seen what we are doing in terms of growth, they’ve only become more bullish on the outlook,” he added. “I’ll say there’s no shortage of folks that want to get a piece of Shield…That was not the case in 2015, 16, and 17, I’ll say that.”
